Portfolio Update

Finsbury Life Sciences Inv Tst PLC 04 October 2004 4 October 2004 FINSBURY LIFE SCIENCES INVESTMENT TRUST PLC (the 'Company') QUARTERLY STATEMENT OF INVESTMENTS In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii), the Company discloses the following: • Investments valuing greater than 5% of the Company's gross assets comprise the following: Company Name Value of Investment at % of Total 30 September 2004 Portfolio Assets Merlin Fund LP 3,074,926 10.84 • The ten largest investments held by the Company comprise the following: Company Name Value of Investment at % of Total 30 September 2004 Portfolio Assets Merlin Fund LP 3,074,926 10.84 Biocompatibles Intl Ord 1,203,580 4.24 Neurosearch 1,108,439 3.91 UK Treasury 4.5% 1,085,313 3.83 Crucell NV 1,022,466 3.60 Evotec Biosystems 987,402 3.48 Vitrolife 939,361 3.31 Icon Spon ADR 865,712 3.05 GPC Biotech NPV 826,891 2.91 Qiagen NV 813,720 2.87 - ENDS - For further information please contact: Tracey Lago, Company Secretary Close Finsbury Asset Management Limited Telephone: 020 7426 6219 This information is provided by RNS The company news service from the London Stock Exchange
UK 100